Literature DB >> 28922205

Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.

Masaki Kaibori1, Kengo Yoshii2, Isao Yokota3, Kiyoshi Hasegawa4, Fumio Nagashima5, Shoji Kubo6, Masanori Kon1, Namiki Izumi7, Masumi Kadoya8, Masatoshi Kudo9, Takashi Kumada10, Michiie Sakamoto11, Osamu Nakashima12, Yutaka Matsuyama13, Tadatoshi Takayama14, Norihiro Kokudo15.   

Abstract

OBJECTIVE: The impact of age on survival after hepatic resection for hepatocellular carcinoma (HCC) has not been thoroughly examined. We reviewed the data of a nationwide follow-up survey to determine the outcomes of hepatectomy for HCC in elderly patients.
BACKGROUND: Management of malignant diseases in elderly patients has become a global clinical issue because of the increased life expectancy worldwide. Advancements in surgical techniques and perioperative management have reduced age-related contraindications for liver surgery.
METHODS: In all, 12,587 patients with HCC who underwent curative hepatic resection were included in this cohort study and classified according to age group [40-59 years (n = 2991), 60-74 years (n = 7576,), and ≥75 years (n = 2020)]. Clinicopathological features, long-term survival, and cumulative incidences of death after hepatic resection were compared among the groups. The cause-specific subdistribution hazard ratios for 3 types of death depending on age were also estimated.
RESULTS: Preoperative liver function tests showed that the prothrombin activity and platelet count were higher in the ≥75-year age group than in the other age groups. The overall survival was significantly lower in the elderly than younger patients. However, recurrence-free survival was almost identical among the 3 groups. The cumulative incidence of HCC-related or liver-related death was almost identical among the 3 groups; however, the cumulative incidence of other causes of death was significantly different. The 60-year subdistribution hazard ratio for other causes of death increased remarkably with increasing age.
CONCLUSIONS: Elderly patients in this nationwide survey had significantly worse overall survival after hepatectomy than middle-aged and young patients. The cumulative incidence of other causes of death in elderly patients was significantly different from that of HCC-related or liver-related death among the 3 groups.

Entities:  

Year:  2019        PMID: 28922205     DOI: 10.1097/SLA.0000000000002526

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

1.  Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.

Authors:  Jae Seok Bae; Dong Ho Lee; Jeongin Yoo; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Haeryoung Kim; Kyung Bun Lee
Journal:  Eur Radiol       Date:  2020-10-07       Impact factor: 5.315

2.  Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a multi-centre propensity score-based analysis.

Authors:  Takeo Nomi; Fumitoshi Hirokawa; Masaki Kaibori; Masaki Ueno; Shogo Tanaka; Daisuke Hokuto; Takehiro Noda; Takuya Nakai; Hisashi Ikoma; Hiroya Iida; Koji Komeda; Morihiko Ishizaki; Shinya Hayami; Hidetoshi Eguchi; Masataka Matsumoto; Ryo Morimura; Hiromitsu Maehira; Masayuki Sho; Shoji Kubo
Journal:  Surg Endosc       Date:  2019-05-15       Impact factor: 4.584

3.  Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study.

Authors:  Jianxing Zeng; Kongying Lin; Huocheng Liu; Yao Huang; Pengfei Guo; Yongyi Zeng; Jinhua Zeng; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2020-07-30       Impact factor: 3.989

4.  The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.

Authors:  Shuangchi Liu; Zhiduan Xu; Zhuling Fang; Dengyong Zhang; Zhongqiang Qin; Longfei Fan; Jiakang Duan; Hongxiang Yin; Yigang Zhang; Qing Pang; Yi Tan
Journal:  Int J Gen Med       Date:  2021-08-10

5.  Hepatocellular carcinoma in old age: are there any benefits of liver resection in old age?

Authors:  In Sik Shin; Deok Gie Kim; Sung Whan Cha; Seong Hee Kang; Sung Hoon Kim; Moon Young Kim; Soon Koo Baik
Journal:  Ann Surg Treat Res       Date:  2020-07-31       Impact factor: 1.859

6.  Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.

Authors:  Bin Yu; Youming Ding; Xiaofeng Liao; Changhua Wang; Bin Wang; Xiaoyan Chen
Journal:  Saudi J Gastroenterol       Date:  2018 Nov-Dec       Impact factor: 2.485

7.  Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.

Authors:  Masatoshi Kudo; Namiki Izumi; Shoji Kubo; Norihiro Kokudo; Michiie Sakamoto; Shuichiro Shiina; Ryosuke Tateishi; Osamu Nakashima; Takamichi Murakami; Yutaka Matsuyama; Arata Takahashi; Hiroaki Miyata; Tadatoshi Takayama
Journal:  Hepatol Res       Date:  2020-01-05       Impact factor: 4.288

8.  Prognostic Role of Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Level in Early Stage Hepatocellular Carcinoma.

Authors:  Joseph Lin; Chih-Jan Ko; Yu-Ju Hung; Ping-Yi Lin; Kuo-Hua Lin; Chia-En Hsieh; Chen-Te Chou; Yao-Li Chen
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

9.  Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.

Authors:  Linxin Teng; Kaiyuan Wang; Yu Liu; Yanxia Ma; Weiping Chen; Lei Bi
Journal:  Biomed Res Int       Date:  2019-10-28       Impact factor: 3.411

10.  Feasibility and safety of surgical microwave ablation for hepatocellular carcinoma in elderly patients: a single center analysis in Japan.

Authors:  Hajime Imamura; Yuko Takami; Tomoki Ryu; Yoshiyuki Wada; Shin Sasaki; Hiroki Ureshino; Hideki Saitsu
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.